Tiptengio 10mg/5mg Tablet
By Tiptengio
Rx
10 Tablet in a Strip

Composition
Empagliflozin(10mg) + Linagliptin(5mg)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
March, 2026

liver
Tiptengio 10mg/5mg Tablet is generally considered safe for use in patients with liver disease. It is advised that there is no need for dose adjustment when using this medication. However, it is important to note that the use of Tiptengio 10mg/5mg Tablet is not recommended for individuals with severe hepatic impairment, as there have not been sufficient studies conducted in such cases. Always consult with your healthcare provider before using Tiptengio 10mg/5mg Tablet, especially if you have severe liver issues.

kidney
Tiptengio 10mg/5mg Tablet requires caution in patients with kidney disease. Dose adjustment may be necessary. Consult your doctor before use. Avoid in severe kidney disease or dialysis.

alcohol
It is advised to avoid consuming alcohol while taking Tiptengio 10mg/5mg Tablet due to potential risks.

driving
It is not clear if Tiptengio 10mg/5mg Tablet affects driving abilities. Avoid driving if you have symptoms impacting concentration and reaction time while using this medication.

pregnancy
Tiptengio 10mg/5mg Tablet may not be safe to use during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor regarding its use during pregnancy.

breastfeeding
Tiptengio 10mg/5mg Tablet may be unsafe while breastfeeding, as it could pass into breastmilk and harm the baby. It is advisable to consult a healthcare provider before using this medication during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹750
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024